/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) today provides an update on PARADIGME, its Phase 2b trial of Betalutin® (177Lu lilotomab satetraxetan) in.
Webcast to be held at 08.30 CEST on Wednesday 6 July OSLO, Norway, July 5, 2022 /PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) today provides an update on PARADIGME, its Phase 2b trial
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces that its Nomination Committee has nominated Dr Thomas Ramdahl for election as a Non-executive.